ADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample

dc.contributor.authorKrämer, Ulrike M.
dc.contributor.authorRojo Fité, Nuria
dc.contributor.authorSchüle, Rebecca
dc.contributor.authorCunillera, Toni
dc.contributor.authorSchöls, Ludger
dc.contributor.authorMarco Pallarés, Josep
dc.contributor.authorCucurell, David
dc.contributor.authorCamara Mancha, Estela
dc.contributor.authorRodríguez Fornells, Antoni
dc.contributor.authorMünte, Thomas F.
dc.date.accessioned2014-09-08T08:58:42Z
dc.date.available2014-09-08T08:58:42Z
dc.date.issued2009-12-20
dc.date.updated2014-09-08T08:58:42Z
dc.description.abstractBackground Dopamine is believed to be a key neurotransmitter in the development of attention-deficit/ hyperactivity disorder (ADHD). Several recent studies point to an association of the dopamine D4 receptor (DRD4) gene and this condition. More specifically, the 7 repeat variant of a variable number of tandem repeats (VNTR) polymorphism in exon III of this gene is suggested to bear a higher risk for ADHD. In the present study, we investigated the role of this polymorphism in the modulation of neurophysiological correlates of response inhibition (Go/Nogo task) in a healthy, high-functioning sample. Results Homozygous 7 repeat carriers showed a tendency for more accurate behavior in the Go/Nogo task compared to homozygous 4 repeat carriers. Moreover, 7 repeat carriers presented an increased nogo-related theta band response together with a reduced go-related beta decrease. Conclusions These data point to improved cognitive functions and prefrontal control in the 7 repeat carriers, probably due to the D4 receptor's modulatory role in prefrontal areas. The results are discussed with respect to previous behavioral data on this polymorphism and animal studies on the impact of the D4 receptor on cognitive functions.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec578090
dc.identifier.issn1471-2202
dc.identifier.pmid20021692
dc.identifier.urihttps://hdl.handle.net/2445/56825
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.1186/1471-2202-10-150; http://dx.doi.org/10.1186/1471-2202-10-150
dc.relation.ispartofBMC Neuroscience, 2009, vol. 10, num. 150
dc.relation.urihttp://dx.doi.org/10.1186/1471-2202-10-150
dc.rightscc-by (c) Krämer, UM. et al., 2009
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Cognició, Desenvolupament i Psicologia de l'Educació)
dc.subject.classificationNeurotransmissors
dc.subject.classificationDopamina
dc.subject.classificationNeurofisiologia
dc.subject.otherNeurotransmitters
dc.subject.otherDopamine
dc.subject.otherNeurophysiology
dc.titleADHD candidate gene (DRD4 exon III) affects inhibitory control in a healthy sample
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
578090.pdf
Mida:
578.29 KB
Format:
Adobe Portable Document Format